| NLRP3 inflammasome activation drives tau pathology C Ising, C Venegas, S Zhang, H Scheiblich, SV Schmidt, A Vieira-Saecker, ... Nature 575 (7784), 669-673, 2019 | 1415 | 2019 |
| Neuroinflammation in Alzheimer disease MT Heneka, WM Van der Flier, F Jessen, J Hoozemanns, DR Thal, ... Nature Reviews Immunology 25 (5), 321-352, 2025 | 320 | 2025 |
| The role of the podocyte in albumin filtration PT Brinkkoetter, C Ising, T Benzing Nature Reviews Nephrology 9 (6), 328-336, 2013 | 286 | 2013 |
| Anaerobic glycolysis maintains the glomerular filtration barrier independent of mitochondrial metabolism and dynamics PT Brinkkoetter, T Bork, S Salou, W Liang, A Mizi, C Özel, S Koehler, ... Cell reports 27 (5), 1551-1566. e5, 2019 | 190 | 2019 |
| Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration C Ising, MT Heneka Cell death & disease 9 (2), 120, 2018 | 146 | 2018 |
| Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms Y Shi, PS Andhey, C Ising, K Wang, LL Snipes, K Boyer, S Lawson, ... Neuron 109 (15), 2413-2426. e7, 2021 | 127 | 2021 |
| Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology MP Kummer, C Ising, C Kummer, H Sarlus, A Griep, A Vieira‐Saecker, ... The EMBO journal 40 (24), e108662, 2021 | 107 | 2021 |
| Inhibition of insulin/IGF‐1 receptor signaling protects from mitochondria‐mediated kidney failure C Ising, S Koehler, S Brähler, C Merkwirth, M Höhne, OR Baris, ... EMBO Molecular Medicine 7 (3), 275-287, 2015 | 94 | 2015 |
| Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria S Brähler, C Ising, H Hagmann, M Rasmus, M Hoehne, C Kurschat, ... American Journal of Physiology-Renal Physiology 303 (10), F1473-F1485, 2012 | 82 | 2012 |
| AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy C Ising, G Gallardo, CEG Leyns, CH Wong, H Jiang, F Stewart, LJ Koscal, ... Journal of Experimental Medicine 214 (5), 1227-1238, 2017 | 71 | 2017 |
| Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease F Brosseron, A Maass, L Kleineidam, KA Ravichandran, PG González, ... Neuron 110 (6), 1009-1022. e4, 2022 | 65 | 2022 |
| Current thinking on the mechanistic basis of Alzheimer's and implications for drug development C Ising, M Stanley, DM Holtzman Clinical Pharmacology & Therapeutics 98 (5), 469-471, 2015 | 65 | 2015 |
| Light microscopic visualization of podocyte ultrastructure demonstrates oscillating glomerular contractions M Höhne, C Ising, H Hagmann, LA Völker, S Brähler, B Schermer, ... The American journal of pathology 182 (2), 332-338, 2013 | 50 | 2013 |
| Quantitative deep mapping of the cultured podocyte proteome uncovers shifts in proteostatic mechanisms during differentiation MM Rinschen, CB Schroeter, S Koehler, C Ising, B Schermer, M Kann, ... American Journal of Physiology-Cell Physiology 311 (3), C404-C417, 2016 | 46 | 2016 |
| Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study F Brosseron, A Maass, L Kleineidam, KA Ravichandran, CC Kolbe, ... Alzheimer's research & therapy 15 (1), 13, 2023 | 42 | 2023 |
| Characterizing microglial senescence: Tau as a key player D Karabag, H Scheiblich, A Griep, F Santarelli, S Schwartz, MT Heneka, ... Journal of Neurochemistry 166 (3), 517-533, 2023 | 31 | 2023 |
| Prohibitin-2 depletion unravels extra-mitochondrial functions at the kidney filtration barrier C Ising, P Bharill, S Brinkkoetter, S Brähler, C Schroeter, S Koehler, ... The American journal of pathology 186 (5), 1128-1139, 2016 | 20 | 2016 |
| The NF-κB essential modulator (NEMO) controls podocyte cytoskeletal dynamics independently of NF-κB S Brähler, C Ising, B Barrera Aranda, M Höhne, B Schermer, T Benzing, ... American Journal of Physiology-Renal Physiology 309 (7), F617-F626, 2015 | 12 | 2015 |
| Chronic inflammation: a potential target in tauopathies C Ising, MT Heneka The Lancet Neurology 22 (5), 371-373, 2023 | 8 | 2023 |
| Prohibitin signaling at the kidney filtration barrier C Ising, PT Brinkkoetter Mitochondrial Dynamics in Cardiovascular Medicine, 563-575, 2017 | 8 | 2017 |
Paul Brinkkoetter, MDUniversity of CologneVerified email at uk-koeln.de
